Cargando…

Epidemiology of Activated Protein C Resistance and Factor V Leiden Mutation in the Mediterranean Region

Venous thromboembolic disorders (VTE) are serious disorders with high morbidity and mortality rates. Many genetic and acquired risk factors were identified to cause VTE. The most common genetic risk factor is Factor V Leiden mutation (FVL). FVL was found in high percentage of populations of Caucasia...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jadaon, Mehrez M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Università Cattolica del Sacro Cuore 2011
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251907/ https://www.ncbi.nlm.nih.gov/pubmed/22224194 http://dx.doi.org/10.4084/MJHID.2011.037

Ejemplares similares

Epidemiology of Prothrombin G20210A Mutation in the Mediterranean Region
por: Jadaon, Mehrez M.
Publicado: (2011)

Factor V Leiden interferes with protein S activity assay
por: Panaget, Baptiste, et al.
Publicado: (2023)

Polymorphisms at activated protein C cleavage sites of factor V: Are they important in the absence of factor V Leiden?
por: Kheradmand, Ehsan, et al.
Publicado: (2017)

Mechanism and pathophysiology of activated protein C-related factor V leiden in venous thrombosis
por: Yusuf, Mohd, et al.
Publicado: (2012)

Factor V Leiden and Inflammation
por: Perez-Pujol, Silvia, et al.
Publicado: (2012)

Myotonic Dystrophy-1 Complicated by Factor-V (Leiden) Mutation
por: Finsterer, Josef, et al.
Publicado: (2015)

Combination of factor V Leiden and MTHFR mutations in myocardial infarction
por: Fekih-Mrissa, Najiba, et al.
Publicado: (2013)

Regional block anesthesia in a patient with factor V Leiden mutation and axillary artery occlusion
por: Erkalp, Kerem, et al.
Publicado: (2011)

Deficiencies of proteins C, S and Antithrombin and factor V Leiden and the risk of ischemic strokes
por: Soare, AM, et al.
Publicado: (2010)

Impact of prothrombin and factor V Leiden mutations on the progression of fibrosis in patients with chronic hepatitis C
por: Naguib, Mary, et al.
Publicado: (2022)

Factor V Leiden mutation: An added risk in single ventricle palliation
por: Saileela, R, et al.
Publicado: (2012)

Multiple Brain Abscesses in an Immunocompetent Patient With Factor V Leiden Mutation
por: Zafar, Saeed Zubair, et al.
Publicado: (2016)

Factor V Leiden Mutation Frequency and Geographical Distribution in Turkish Population
por: Yıldız, Eray, et al.
Publicado: (2020)

Homozygous factor V leiden mutation: Rare etiology of pulmonary embolism
por: el marraki, Zakaria, et al.
Publicado: (2022)

Ophthalmic Vein Thrombosis Associated with Factor V Leiden and MTHFR Mutations
por: Teodoru, Cosmin Adrian, et al.
Publicado: (2023)

The Association of Coagulation Factor V (Leiden) and Factor II (Prothrombin) Mutations With Stroke
por: Pirhoushiaran, Maryam, et al.
Publicado: (2014)

Papillophlebitis Associated With Coexisting Heterozygous Mutations of Factor V Leiden and Methylenetetrahydrofolate Reductase Enzyme-(C677T)
por: Ntora, Efthalia, et al.
Publicado: (2021)

Recurrent pregnancy loss: can factor V Leiden mutations be a cause
por: Reddy, R R N, et al.
Publicado: (2019)

The characterization and antibiotic resistance profiles of clinical Escherichia coli O25b-B2-ST131 isolates in Kuwait
por: Dashti, Ali A, et al.
Publicado: (2014)

The emergence of plasmid mediated quinolone resistance qnrA2 in extended spectrum β-lactamase producing Klebsiella pneumoniae in the Middle East
por: Vali, Leila, et al.
Publicado: (2015)

American College of Medical Genetics Consensus Statement on Factor V Leiden Mutation Testing
por: Grody, Wayne W., et al.
Publicado: (2001)

Pneumococcal meningitis and endocarditis in an infant: possible improved survival with factor V Leiden mutation
por: Mohapatra, Sitikant, et al.
Publicado: (2017)

Arterial Thrombosis Associated with Factor V Leiden Mutation in a Child with Nephrotic Syndrome
por: Nagalla, Vamsi Krishna, et al.
Publicado: (2021)

A novel factor V mutation causes a normal activated protein C ratio despite the presence of a heterozygous F5 R506Q (factor V Leiden) mutation
por: Prüller, Florian, et al.
Publicado: (2013)

Education Case: Hereditary Thrombophilia With Double Heterozygous Factor V Leiden and Factor II c.*97G>A Mutations
por: Abukhiran, Ibrahim, et al.
Publicado: (2021)

Perioperative Management of Factor V Leiden and Pancreatic Adenocarcinoma
por: O'Malley, Thomas J., et al.
Publicado: (2017)

Investigation of methylenetetrahydrofolate reductase C677T and factor V Leiden mutation as a genetic marker for retinal vein occlusion
por: Nema, Nitin, et al.
Publicado: (2018)

Factor V Leiden, Factor II, Protein C, Protein S, and Antithrombin and Ischemic Strokes in Young Adults: A Meta-Analysis
por: Tsalta-Mladenov, Mihael, et al.
Publicado: (2022)

Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients
por: Kreidy, Raghid
Publicado: (2012)

Impact of the factor V Leiden mutation on the outcome of pneumococcal pneumonia: a controlled laboratory study
por: Schouten, Marcel, et al.
Publicado: (2010)

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients
por: Akın, Dilara Fatma, et al.
Publicado: (2012)

Evaluation the frequency of factor V Leiden mutation in pregnant women with preeclampsia syndrome in an Iranian population
por: Karimi, Samieh, et al.
Publicado: (2012)

Pharmacogenetic typing for oral anti-coagulant response among factor V Leiden mutation carriers
por: Nahar, Risha, et al.
Publicado: (2012)

Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation
por: Klerk, CPW, et al.
Publicado: (2007)

Post-Partum Ovarian Vein Thrombosis: Combined Effect of Infection and Factor V Leiden Mutation
por: Farran, H. El, et al.
Publicado: (2015)

Skin Necrosis in a Patient with Factor V Leiden Mutation following Nipple Sparing Mastectomy
por: Bingol, Ugur Anil, et al.
Publicado: (2015)

Impedimetric Sensing of Factor V Leiden Mutation by Zip Nucleic Acid Probe and Electrochemical Array
por: Erdem, Arzum, et al.
Publicado: (2020)

High prevalence of protein C, protein S, antithrombin deficiency, and Factor V Leiden mutation as a cause of hereditary thrombophilia in patients of venous thromboembolism and cerebrovascular accident
por: Ali, Nadir, et al.
Publicado: (2014)

The Role of Factor V Leiden, Prothrombin G20210A, and MTHFR C677T Mutations in Neonatal Cerebral Sinovenous Thrombosis
por: Garrido-Barbero, Maria, et al.
Publicado: (2019)

Sclerosing Mesenteritis in a Patient Heterozygous for Factor V Leiden
por: Reddington, Hayley, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rsq1bvps7njrc1fa2q9ooboe68